A small group of parent advocates is mobilizing “gentle propaganda” against vaccine naysayers
vaccination
Study Finds Small Risk Of Guillain-Barre Syndrome From H1N1 Vaccine
Public health experts say the benefits of vaccination still far outweigh the risks
Family MattersVaccines
In Global Push for Vaccination, Moms Give Kids a Shot@Life
To promote the need for immunizations, public health groups turn to mothers.
Protection from Whooping Cough Vaccine Wanes Over Time
Vaccines are by far the best defense against pertussis, or whooping cough. But protection among kids dwindles with every year since the last dose of vaccine, a new CDC study finds
H1N1 Vaccines Linked to Guillain-Barre Syndrome but Not Birth Defects
Two new studies confirm that the benefits of getting a flu shot outweigh the very small risks
Family MattersParenting
Are Vaccines Safe? A Major Media Outlet’s Specious Story Fans the Debate
The Learning Channel’s website yanked a story that was riddled with mistruths and flat-out errors — but only after major medical organizations complained.
Government Panel Recommends HPV Vaccine for Boys
A federal advisory committee voted on Tuesday to recommend that boys aged 11 and 12 be vaccinated against human papillomavirus, or HPV, to protect against anal cancer and cancers of the mouth and neck. The new guidance mirrors …
Family MattersInfancy
New Guidelines: How to Put Baby Safely to Bed
Sleeping like a baby is now more regimented than ever, in light of updated guidelines by the American Academy of Pediatrics (AAP) about how best to put baby to bed to reduce the risk of SIDS, or sudden infant death syndrome.
1 in 10 Parents Skip or Delay Vaccines
More than one in 10 parents don’t follow the recommended vaccination schedule for their children, according to a new study. And one in four who do adhere to current guidelines say they still feel that it may not be the best or …
With the HPV Vaccine, Two Doses May Be Just as Good as Three
Two doses of the vaccine that protects against human papillomavirus (HPV) may be just as effective as the three-dose regimen that is currently recommended, according to the latest research from the National Cancer Institute (NCI).
